ViewRay, Inc.
VRAY
VRAY was delisted on the 25th of July, 2023.
144 hedge funds and large institutions have $744M invested in ViewRay, Inc. in 2019 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 54 increasing their positions, 38 reducing their positions, and 15 closing their positions.
73% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 15
42% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 38
25% more capital invested
Capital invested by funds: $596M → $744M (+$148M)
6% more funds holding
Funds holding: 136 → 144 (+8)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
29% less call options, than puts
Call options by funds: $4.57M | Put options by funds: $6.42M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GC
Greenvale Capital
London,
United Kingdom
|
+$18.1M |
| 2 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$15.1M |
| 3 |
PVI
Pura Vida Investments
New York
|
+$7.09M |
| 4 |
PA
Perceptive Advisors
New York
|
+$6.94M |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$3.88M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$12.8M |
| 2 |
RI
RTW Investments
New York
|
-$9.29M |
| 3 |
Millennium Management
New York
|
-$6.63M |
| 4 |
ACM
Archon Capital Management
Seattle,
Washington
|
-$4.39M |
| 5 |
NC
Northpointe Capital
Bloomfield Hills,
Michigan
|
-$2.83M |
VRAY Hedge Fund Activity: Q1 2019 in Review
144 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in ViewRay, Inc. (VRAY) for Q1 2019, worth a combined $744M — up 25% from $596M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new VRAY positions and 15 closed out — a net gain of 11 holders — while 54 added to existing stakes and 38 trimmed.
The largest buyer was Greenvale Capital, opening a new position worth an estimated $18.1M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $12.8M sold.
- 144 institutional investors held ViewRay, Inc. (VRAY) as of Q1 2019, up from 136 in Q4 2018.
- Funds reported $744M of ViewRay, Inc. stock for Q1 2019, up 25% quarter-over-quarter.
- 26 funds opened new ViewRay, Inc. positions in Q1 2019 and 15 closed out, a net change of +11 holders.
- The largest ViewRay, Inc. buyer in Q1 2019 was Greenvale Capital, an estimated $18.1M added.
- The largest ViewRay, Inc. seller in Q1 2019 was PFM Health Sciences, an estimated $12.8M sold.
Based on aggregated 13F filings for Q1 2019.